YUHSpace: Browsing DSpace
menu
About
Yonsei University Medical Library
검색
All
Title
Author
Keyword / MeSH
Year
Journal Title
Contains
Equals
YUHASpace Repository
YUHSpace
About YUHSpace
Guildeline
BROWSE
Colleges & Departments
Yonsei Authors
Titles
Journal Titles
Publication Year
YUHS Publication
(연세의료원 간행물)
YUHSpace
1. College of Medicine (의과대학)
BioMedical Science Institute (의생명과학부)
1. Journal Papers
Browsing "1. Journal Papers" by Author : 4088
All
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
가
나
다
라
마
바
사
아
자
차
카
타
파
하
All
가
나
다
라
마
바
사
아
자
차
카
타
파
하
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
or enter first few letters:
Sort by:
title
issue date
submit date
In order:
Ascending
Descending
Results/Page
5
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
95
100
Authors/Record:
All
1
5
10
15
20
25
30
35
40
45
50
Showing results 18 to 29 of 29
This table browses all dspace content
Issue Date
Title
Journal Title
2022
Molecular landscape of osimertinib resistance in patients and patient-derived preclinical models
THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY
2019
Patient-Derived Cells to Guide Targeted Therapy for Advanced Lung Adenocarcinoma
SCIENTIFIC REPORTS
2016
PD-L1 expression on immune cells, but not on tumor cells, is a favorable prognostic factor for head and neck cancer patients
SCIENTIFIC REPORTS
2015
Phase II clinical and exploratory biomarker study of dacomitinib in recurrent and/or metastatic esophageal squamous cell carcinoma
ONCOTARGET
2023
Polo-like Kinase 4: A Multifaceted Marker Linking Tumor Aggressiveness and Unfavorable Prognosis, and Insights into Therapeutic Strategies
CANCERS
2022
Primary Tumor Suppression and Systemic Immune Activation of Macrophages through the Sting Pathway in Metastatic Skin Tumor
YONSEI MEDICAL JOURNAL
2019
Promising preclinical platform for evaluation of immuno-oncology drugs using Hu-PBL-NSG lung cancer models
LUNG CANCER
2021
Role and Function of O-GlcNAcylation in Cancer
CANCERS
2019
Targeting YAP to overcome acquired resistance to ALK inhibitors in ALK-rearranged lung cancer
EMBO MOLECULAR MEDICINE
2021
The promise of bispecific antibodies: Clinical applications and challenges
CANCER TREATMENT REVIEWS
2019
YH25448, an Irreversible EGFR-TKI with Potent Intracranial Activity in EGFR Mutant Non-Small Cell Lung Cancer
CLINICAL CANCER RESEARCH
2022
YH29407 with anti-PD-1 ameliorates anti-tumor effects via increased T cell functionality and antigen presenting machinery in the tumor microenvironment
FRONTIERS IN CHEMISTRY
1
Browse
Communities & Collections
Titles
Yonsei Authors
Journal Titles
By date
Links
About
Yonsei University Medical Library